丹参川芎嗪注射液联合西药对急性缺血性脑卒中患者脑组织的保护作用及对预后的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.3

基金项目:


ProtectiveEffectofDanshenChuanxiongqin InjectionCombinedwithWestern Medicine on Brain Tissue in Patients with Acute Ischemic Stroke and Its Effect on Prognosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察丹参川芎嗪注射液联合西药治疗对急性缺血性脑卒中患者脑组织的保护作用及对预后的影响。方法:以268例急性缺血性脑卒中患者为研究对象,按随机数字表法分为研究组和对照组各134例,2组均予西药治疗,研究组予以丹参川芎嗪注射液联合治疗,2组均随访至12周。治疗前后检测2组患者的血清炎症相关因子[超敏C-反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)]、血管内皮生长因子(VEGF)、神经元特异性烯醇化酶(NSE)和S-100β水平,随访评定患者治疗12周内的美国国立卫生研究院卒中量表(NIHSS)评分和日常生活能力量表(BI)评分。结果:治疗3周,2组hs-CRP、TNF-α、IL-6和IL-8水平均低于入院时(P<0.01);研究组各因子水平均低于对照组(P<0.01)。2组血清NSE和S-100β水平均较入院时降低(P<0.01),而VEGF水平较入院时升高(P<0.01)。研究组血清NSE和S-100β水平均低于对照组,VEGF水平高于对照组,差异均有统计学意义(P<0.01)。2组治疗后一时间点的NIHSS评分均低于同组治疗前一时间点(P<0.01),而2组治疗后一时间点的BI评分均高于同组治疗前一时间点水平(P<0.01)。治疗6周和12周,研究组的NIHSS评分均低于对照组(P<0.01),而BI评分均高于对照组(P<0.01)。结论:丹参川芎嗪注射液联合西药治疗可以有效减轻急性缺血性脑卒中患者的血管炎症反应程度、血管内皮细胞和脑组织的损伤程度,促进大脑神经细胞修复,提高患者卒中后的生活能力,防止卒中后肢体发生功能障碍,改善患者预后。

    Abstract:

    Objective: To observe the protective effect of Danshen Chuanxiongqin injection combined with western medicine on brain tissue in patients with acute ischemic stroke and its effect on prognosis.Methods:A total of 268 cases of patients with acute ischemic stroke were selected as the study subjects,and were divided into the study group and the control group according to the random number table method,134 cases in each group.Both groups were treated with western medicine,and the study group was additionally treated with Danshen Chuanxiongqin injection.Both groups were followed up for 12 weeks.Before and after treatment,the levels of the inflammatory factors in serum including highsensitivity C-reactive protein(hs-CRP),tumor necrosis factor- α(TNF- α),interleukin-6(IL-6)and interleukin-8(IL-8),the vascular endothelial growth factor(VEGF), the neuron-specific enolase(NSE)and the S-100β in the two groups were detected.The scores of National Institutes of Health Stroke Scale(NIHSS)and Barthel Index(BI)of patients within 12 weeks of treatment were evaluated during follow-up.Results:After treatment for three weeks,the levels of hs-CRP,TNF-α,IL-6 and IL-8 in the two groups were lower than those before admission(P < 0.01);and the levels in the study group were lower than those in the control group(P<0.01).The levels of NSE and S-100β in serum in the two groups were decreased when compared with those before admission(P< 0.01),and the levels of VEGF were increased when compared with those before admission(P < 0.01).The levels of NSE and S-100β in serum in the study group were lower than those in the control group,and the level of VEGF was higher than that in the control group,differences being significant(P<0.01).The NIHSS scores at a time point after treatment in both groups were lower than those before treatment in the same group respectively(P<0.01),while the BI scores at a time point after treatment in both groups were higher than those before treatment in the same group respectively(P< 0.01).At the 6thand 12thweeks of treatment,NIHSS score in the study group was lower than that in the control group(P<0.01),while BI score was higher(P<0.01).Conclusion:The therapy of Danshen Chuanxiongqin injection combined with western medicine in treating patients with acute ischemic stroke can effectively reduce the degree of vascular inflammatory responses and the damage degree of vascular endothelial cells and brain tissue,promote the recovery of neurons in the cerebrum,improve living ability after stroke,prevent limb dysfunction after stroke and improve the prognosis of patients.

    参考文献
    相似文献
    引证文献
引用本文

许玉华.丹参川芎嗪注射液联合西药对急性缺血性脑卒中患者脑组织的保护作用及对预后的影响[J].新中医,2020,52(1):66-70

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-01-06
  • 出版日期: